Marc Loyens

1.4k total citations
36 papers, 1.2k citations indexed

About

Marc Loyens is a scholar working on Epidemiology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Marc Loyens has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 15 papers in Immunology and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Marc Loyens's work include Trypanosoma species research and implications (22 papers), Research on Leishmaniasis Studies (14 papers) and Biochemical and Molecular Research (6 papers). Marc Loyens is often cited by papers focused on Trypanosoma species research and implications (22 papers), Research on Leishmaniasis Studies (14 papers) and Biochemical and Molecular Research (6 papers). Marc Loyens collaborates with scholars based in France, Belgium and Venezuela. Marc Loyens's co-authors include Odile Billaut‐Mulot, Thierry Idziorek, Ameisen Jc, Moníque Capron, Gaëtane Woerly, Ali Ouaissi, David Dombrowicz, A. Taibi, Ali Ouaissi and A Capron and has published in prestigious journals such as Nucleic Acids Research, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Marc Loyens

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Loyens France	19	528	476	431	305	158	36	1.2k
F F Richards United States	18	669 1.3×	426 0.9×	195 0.5×	294 1.0×	107 0.7×	32	1.4k
F. Klotz France	20	313 0.6×	416 0.9×	1.3k 3.0×	777 2.5×	324 2.1×	94	2.1k
Manju B. Joshi United States	17	543 1.0×	368 0.8×	656 1.5×	273 0.9×	263 1.7×	28	1.2k
Laurent Fischer France	25	974 1.8×	547 1.1×	341 0.8×	308 1.0×	66 0.4×	44	2.1k
Kayoko Tsuda Japan	9	756 1.4×	463 1.0×	331 0.8×	259 0.8×	138 0.9×	11	1.3k
Susana Romão Switzerland	13	480 0.9×	261 0.5×	277 0.6×	170 0.6×	104 0.7×	15	802
Ana Carolina Oliveira Brazil	17	413 0.8×	202 0.4×	367 0.9×	266 0.9×	123 0.8×	29	828
Luciana Barros de Arruda Brazil	21	295 0.6×	240 0.5×	580 1.3×	361 1.2×	77 0.5×	42	1.2k
Willie L. Chapman United States	20	503 1.0×	249 0.5×	701 1.6×	141 0.5×	193 1.2×	63	1.3k
Helton C. Santiago Brazil	25	561 1.1×	309 0.6×	606 1.4×	412 1.4×	689 4.4×	66	1.8k

Countries citing papers authored by Marc Loyens

Since Specialization

Citations

This map shows the geographic impact of Marc Loyens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Loyens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Loyens more than expected).

Fields of papers citing papers by Marc Loyens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Loyens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Loyens. The network helps show where Marc Loyens may publish in the future.

Co-authorship network of co-authors of Marc Loyens

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Loyens. A scholar is included among the top collaborators of Marc Loyens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Loyens. Marc Loyens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wyndham-Thomas, Chloé, Violette Dirix, Kinda Schepers, et al.. (2015). Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON®-TB Gold In-tube. BMC Infectious Diseases. 15(1). 59–59. 14 indexed citations

Wyndham-Thomas, Chloé, Véronique Corbière, Violette Dirix, et al.. (2014). Key Role of Effector Memory CD4⁺T Lymphocytes in a Short-Incubation Heparin-Binding Hemagglutinin Gamma Interferon Release Assay for the Detection of Latent Tuberculosis. Clinical and Vaccine Immunology. 21(3). 321–328. 27 indexed citations

Decot, Véronique, Gaëtane Woerly, Marc Loyens, et al.. (2005). Heterogeneity of Expression of IgA Receptors by Human, Mouse, and Rat Eosinophils. The Journal of Immunology. 174(2). 628–635. 31 indexed citations

Woerly, Gaëtane, et al.. (2003). Inhibition of Human Eosinophil Functions by Ketotifen in vitro. Investigative Ophthalmology & Visual Science. 44(13). 1294–1294. 2 indexed citations

Woerly, Gaëtane, Sylvie Loiseau, Marc Loyens, Christian Schoch, & Moníque Capron. (2003). Inhibitory effects of ketotifen on eotaxin‐dependent activation of eosinophils: consequences for allergic eye diseases. Allergy. 58(5). 397–406. 25 indexed citations

Billaut‐Mulot, Odile, Thierry Idziorek, Marc Loyens, A Capron, & George M. Bahr. (2001). Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost. Vaccine. 19(20-22). 2803–2811. 26 indexed citations

Billaut‐Mulot, Odile, Thierry Idziorek, Elisabeth Ban, et al.. (2000). Interleukin-18 modulates immune responses induced by HIV-1 Nef DNA prime/protein boost vaccine. Vaccine. 19(1). 95–102. 35 indexed citations

Amiel, Corinne, Edith Darcissac, Marie‐José Truong, et al.. (1999). Interleukin‐16 (IL‐16) Inhibits Human Immunodeficiency Virus Replication in Cells from Infected Subjects, and Serum IL‐16 Levels Drop with Disease Progression. The Journal of Infectious Diseases. 179(1). 83–91. 53 indexed citations

Ouaissi, M. A., Jean‐François Dubremetz, Ralf Schöneck, et al.. (1995). Trypanosoma cruzi: A 52-kDa Protein Sharing Sequence Homology with Glutathione S-Transferase Is Localized in Parasite Organelles Morphologically Resembling Reservosomes. Experimental Parasitology. 81(4). 453–461. 34 indexed citations

10.

Schöneck, Ralf, A. Taibi, Odile Billaut‐Mulot, et al.. (1994). Trypanosoma cruzi cDNA encodes a tandemly repeated domain structure characteristic of small stress proteins and glutathione S‐transferases. Biology of the Cell. 80(1). 1–10. 32 indexed citations

11.

Yahiaoui, Bilal, Marc Loyens, A. Taibi, et al.. (1993). Characterization of aLeishmaniaantigen associated with cytoplasmic vesicles resembling endosomal-like structure. Parasitology. 107(5). 497–507. 13 indexed citations

12.

Taibi, A., Hilzeth de Luna Freire Pêssoa, Claudie Verwaerde, et al.. (1993). Trypanosoma cruzi glutathione-binding proteins (TcGBP) : protection induced by native proteins in an experimental model and analysis of the antibody response. Research in Immunology. 144(8). 553–563. 9 indexed citations

13.

Billaut‐Mulot, Odile, Ralf Schöneck, A. Taibi, et al.. (1993). Nucleotide sequence of aTrypanosoma cruzicDNA encoding a protein homologous to mammalian EF1γ. Nucleic Acids Research. 21(16). 3901–3901. 11 indexed citations

14.

Ouaissi, Ali, J. Cornette, Ralf Schöneck, et al.. (1992). Fibronectin cleavage fragments provide a growth factor-like activity for the differentiation of Trypanosoma cruzi trypomastigotes to amastigotes.. PubMed. 59(1). 68–79. 14 indexed citations

15.

Ouaissi, M. A., A. Taibi, Marc Loyens, et al.. (1991). Trypanosoma Cruzi: a Carbohydrate Epitope Defined by a Monoclonal Antibody as a Possible Marker of the Acute Phase of Human Chagas' Disease. American Journal of Tropical Medicine and Hygiene. 45(2). 214–225. 12 indexed citations

16.

Ouaissi, M. A., A. Taibi, J. Cornette, et al.. (1990). Characterization of major surface and excretory-secretory immunogens ofTrypanosoma cruzitrypomastigotes and identification of potential protective antigen. Parasitology. 100(1). 115–124. 37 indexed citations

17.

Taibi, A., et al.. (1990). Trypanosoma cruzi: IgM antibodies to an 84 kDa polypeptide epitope as a possible marker of the acute phase of human Chagas' disease.. Medical science research. 18(18). 725–726. 1 indexed citations

18.

Ouaissi, M. A., Jean‐François Dubremetz, J P Kusnierz, et al.. (1990). Trypanosoma cruzi: Differential expression and distribution of an 85-kDa polypeptide epitope by in vitro developmental stages. Experimental Parasitology. 71(2). 207–217. 16 indexed citations

19.

Afchain, D., et al.. (1989). Trypanosoma cruzi: circulating polysaccharide factors excreted in vitro and in vivo.. PubMed. 49(1). 33–6. 2 indexed citations

20.

Lemesre, J. L., Farrukh S. Rizvi, F Santoro, et al.. (1988). Autorégulation de la croissance in vitro des Trypanosomatidae. Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie. 307(5). 283–288. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact